Entest adds Tammy Reynolds as CFO
This article was originally published in Clinica
Executive Summary
Stem cell therapy specialist Entest BioMedical has appointed Tammy Reynolds to the position of CFO. Ms Reynolds joins the firm from Science Applications International Corporation and previously worked as a senior accountant in the areas of financial reporting and tax compliance. La Mesa, California-based Entest specialises in developing stem cell treatments for chronic obstructive pulmonary disease (COPD), immuno-cancer therapies, tests for diabetes and stem cell research applications for diabetes and other illnesses. The firm also developing the ENT-576 laser device for stem cell extraction.